33rd Annual Symposium on NHP Models for AIDS

 描述(由申请人提供)：本R13申请申请资金部分用于支持第33届艾滋病非人类灵长类动物模型年度研讨会的策划、组织、宣传和主办费用。研讨会将由加州大学戴维斯分校(UC Davis)加州国家灵长类研究中心(CNPRC)主办，于2015年10月14-16日在加利福尼亚州蒙特利的波托拉酒店举行。艾滋病非人类灵长类动物模型年度研讨会已经成为分享、展示和交流利用非人类灵长类艾滋病模型进行艾滋病研究的最新进展的目的地。根据过去参加会议的记录，预计将有来自国家和国际学术机构和私营企业的约250名科学家出席。将介绍在病毒发病机制、免疫学、病毒学、疫苗、治疗学和基因组学方面的最新发现。将讨论根除艾滋病毒战略的新方法。今年研讨会的重点是为临床医生和研究人员之间的对话提供论坛，以促进改进艾滋病毒的动物模型，以加强对动物的预防、治疗和治愈结果对艾滋病毒患者的翻译。会议将包括平台介绍和招贴会议。科学会议将专门讨论具体的重点研究领域。每届会议将由一名特邀主席和一名联合主席主持。主席将主持会议的前半部分，并将在会议开始时作30分钟的概要介绍。联席主席将主持会议的后半段，并在每届会议结束时促进讨论。科学计划委员会由代表国家灵长类中心、学术机构以及制药和生物技术行业的14名成员组成，委员会将审查摘要，并为每一次科学会议分配口头或海报演示。大会组委会(9名成员)将参与大会的策划和组织工作。选择摘要的标准将是 基于内容的原创性和质量。那些发表讲台演讲的人将被要求以手稿的形式提交他们的演讲，并在《医学灵长类动物学杂志》上发表(杜兰大学的普雷斯顿·马克思博士将担任编辑)。此外，还将为那些不能在五个平台会议中安排的有功发言安排海报会议。会议将包括开幕当天的欢迎招待会和介绍性演讲(加州大学戴维斯分校Murray Gardner博士)，然后是NIH主任先锋奖获得者James Hildreth博士(加州大学戴维斯分校/梅哈里大学)的主旨演讲。第二天，将举行平台推介和海报环节招待会。在研讨会的第三天，将在平台介绍和海报会议之后举行宴会。拟议的会议将促进交流最新的发现、新的想法和概念以及协作互动，以确定艾滋病毒疾病的机制，并为预防感染的艾滋病毒疫苗和控制和根除艾滋病毒感染的治疗方法的创新研究发展多学科协作互动。

 DESCRIPTION (provided by applicant): This R13 application request funds to partially support the costs for planning, organizing, publicizing, and hosting the 33rd Annual Symposium on Nonhuman Primate Models for AIDS. The Symposium will be hosted by the California National Primate Research Center (CNPRC), University of California, Davis (UC Davis), and will be held on October 14-16, 2015, at the Portola Hotel, Monterey, California. The Annual Symposium on Nonhuman Primate Models for AIDS has become the destination for the sharing, presenting and exchanging the most recent advances in AIDS research utilizing nonhuman primate models of AIDS. An attendance of approximately 250 scientists from national and international academic institutions and private industry is expected based on the past records of the conference participation. The most recent findings in viral pathogenesis, immunology, virology, vaccines, therapeutics, and genomics will be presented. Novel approaches for HIV eradication strategies will be discussed. An emphasis of this year's symposium is to provide forums for dialog between clinicians and researchers to facilitate refinement of the animal models of HIV in ways that enhance translation of prevention, treatment, and cure findings in animals to HIV patients. The meeting will consist of a combination of platform presentations and poster sessions. The scientific sessions will be devoted to specific focus areas of research. Each session will be hosted by an invited Chair and a co-Chair. The Chair will moderate the first half of the session and will begin the session by giving a 30- minute overview presentation. The co-Chair will moderate the second half of the session and facilitate discussion at the end of each session. The Scientific Program Committee consists of 14 members representing the National Primate Centers, academic institutions, and pharmaceutical and biotechnology industry, and the committee will review abstracts and assign oral or poster presentation for each of the scientific sessions. The conference organizing committee (nine members) will participate in the planning and organization of the conference. Criteria for selection of the abstracts will be based on the originality and quality of the content. Those individuals giving platform presentations will be asked to submit their presentations in manuscript form for publication in the Journal of Medical Primatology (Dr. Preston Marx, Tulane, will serve as Editor). In addition, there will be poster sessions for those meritorious presentations that cannot be accommodated in one of the five platform sessions. The conference will include an opening day welcome reception and introductory talk (Dr. Murray Gardner, UC Davis) followed by a keynote presentation by Dr. James Hildreth (UC Davis/Meharry University), recipient of the NIH Director's Pioneer Award. On the second day, platform presentations and a poster session reception will be held. On the third day of the symposium, a banquet will be hosted following the platform presentations and a poster session. The proposed conference will facilitate an exchange of most recent findings, new ideas and concepts and collaborative interactions to define the mechanisms of HIV disease and to develop multi-disciplinary collaborative interactions for innovative studies on HIV vaccines to prevent infection and therapies to control and eradicate HIV infection.